MAT
43
-2
SYK
44
-2
NVDA
52
-2
NKE
31
-3
ADM
34
-2
STX
50
-2
AAP
27
6
DHR
50
-20
SYY
48
3
PPG
41
-2
ALLE
37
-18
DGX
44
-20
ITW
34
-3
PVH
38
10
TJX
53
9
LB
71
-4
COP
54
-8
AAL
24
-2
FLR
42
-6
MAC
39
-11
MAT
43
-2
SYK
44
-2
NVDA
52
-2
NKE
31
-3
ADM
34
-2
STX
50
-2
AAP
27
6
DHR
50
-20
SYY
48
3
PPG
41
-2
ALLE
37
-18
DGX
44
-20
ITW
34
-3
PVH
38
10
TJX
53
9
LB
71
-4
COP
54
-8
AAL
24
-2
FLR
42
-6
MAC
39
-11
Financhill
Back

Inovio Pharmaceuticals 10K Form

Sell
30

INO
Inovio Pharmaceuticals

Last Price:
$1.92
Seasonality Move:
1.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $217.8K
Cash Flow: $-19.7M
Price / Cash Flow: 0
Annual Sales: $1.90
Price / Book: 1.04

Profitability

EPS (TTM): -3.99000
Net Income (TTM): $-107.3M
Gross Margin: $0
Return on Equity: -119.02%
Return on Assets: -81.98%

Inovio Pharmaceuticals Earnings Forecast

Key Inovio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for INO is 0.00%.
  • The Selling, General & Administrative Expenses for INO have been equal to 16,989.50% of Gross Profit Margin.
  • The Research & Development expenses have been 34,726.46% of Revenue.
  • The Net Earning history of INO is -49,253.37% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Inovio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.77
Quick Ratio: 2.7

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Sell
30
Inovio Pharmaceuticals (INO) is a Sell

Is Inovio Pharmaceuticals a Buy or a Sell?